Publication:
Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Simple item page
dc.contributor.authorWirongrong Chierakulen_US
dc.contributor.authorSiriluck Anunnatsirien_US
dc.contributor.authorWipada Chaowagulen_US
dc.contributor.authorSharon J. Peacocken_US
dc.contributor.authorPloenchan Chetchotisakden_US
dc.contributor.authorNicholas P. Dayen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.contributor.otherSappasitthiprasong Hospitalen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-08-24T02:02:19Z
dc.date.available2018-08-24T02:02:19Z
dc.date.issued2007-08-15en_US
dc.identifier.citationClinical Infectious Diseases. Vol.45, No.4 (2007), 521-523en_US
dc.identifier.doi10.1086/520011en_US
dc.identifier.issn10584838en_US
dc.identifier.other2-s2.0-34547647816en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/24784
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34547647816&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleAddition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]en_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34547647816&origin=inwarden_US

Files

Collections

Scopus 2006-2010